Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vilaprisan in Uterine Fibroids (ASTEROID 1)
NCT02131662Phase 2Completed
- Sponsor
- Bayer
- Start
- May 2014
- Primary completion
- May 2016
- Modality
- Orthosteric Ligands
- Countries
- 13
01
Overview
Phase 2, randomised, double-blind trial of vilaprisan in Uterine Fibroids (UF) (5 arms), sponsored by Bayer. Primary endpoint: Percentage of Subjects With Amenorrhea at 12 weeks. Started May 2014; status: completed.
02
Drugs
vilaprisan
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT02131662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02131662.